These findings collectively demonstrate that inhibition of the PI3Kγ and PD-L1 signaling pathways enhances CD8+ T-cell tumor infiltration and reduces the expression of markers of CD8+ T-cell dysfunction in the tumor microenvironment. The gene discussed is CD8A; the disease is neoplasm.